
Rich Gelfond ended his leave at J.P. Morgan conference, revealing a buyback of over 12 million shares in one week. The move signals management's view that IMAX is undervalued ahead of summer slate.
IMAX CORP currently carries an Alpha Score of n/a, giving AlphaScala's model a neutral read on the setup.
IMAX Corporation CEO Rich Gelfond ended his temporary leave of absence by appearing via video at the J.P. Morgan 54th Annual Global Technology, Media and Communications Conference on May 19, 2026. The headline from his appearance was a capital allocation decision that changes the near-term math for shareholders: a buyback program that has already retired over 12 million shares in the past week.
Gelfond framed the buyback as the first major move of his return, telling the audience that his primary focus is increasing shareholder value. “In the last week or two, we decided to initiate a buyback program a week ago, and we bought in over 12 million shares,” he said. The scale is the key detail. A single week of repurchasing at that volume is not a routine capital return. It is a concentrated bet that IMAX’s own equity offers the best risk-adjusted return available to management.
The stock had declined as some film titles “over-indexed” in ways that hurt IMAX’s fraction of the box office, according to Gelfond. The buyback directly counters that selloff. By stepping in as a buyer, management is putting cash behind the conviction that the market price undervalues the business. The mechanism is straightforward: fewer shares outstanding means each dollar of earnings flows to a smaller base, boosting EPS even if absolute profit stays flat. The buyback also removes some of the overhang from Gelfond’s absence, a leadership uncertainty that likely contributed to the stock’s slide.
CFO Natasha Fernandes joined the session in person, reinforcing that the capital allocation decision had full executive support. The buyback’s size relative to IMAX’s typical share count implies that management sees a material dislocation between the market price and intrinsic worth.
The buyback alone does not fix the film-slate risk that weighed on the stock earlier this year. IMAX’s performance still depends heavily on the lineup of blockbuster releases. Gelfond linked his return timing to the summer movie season, calling the slate “perfect” for IMAX. The real test will come as actual box office numbers roll in over the next several weeks.
If the summer titles deliver strong IMAX attendance, the buyback will look prescient. If the slate underwhelms, the stock could remain under pressure even with the reduced share count. Investors now have a dual focus: watch for further buyback activity in subsequent filings, and track IMAX’s share of the summer box office.
The next concrete decision point is the company’s next 13-F or earnings release, which will disclose whether the buyback continued at pace. Gelfond’s return removes one layer of uncertainty. The buyback removes another. The summer slate will answer the rest. For broader context on how capital allocation signals interact with sector trends, see our stock market analysis.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.